Published in Appl Environ Microbiol on October 01, 1985
The genus Aeromonas: taxonomy, pathogenicity, and infection. Clin Microbiol Rev (2010) 7.09
Impact of the ring-billed gull (Larus delawarensis) on the microbiological quality of recreational water. Appl Environ Microbiol (1993) 1.47
Foodborne pathogens recovered from ready-to-eat foods from roadside cafeterias and retail outlets in Alice, Eastern Cape Province, South Africa: public health implications. Int J Environ Res Public Health (2012) 1.46
Improved membrane filtration media for enumeration of total coliforms and Escherichia coli from sewage and surface waters. Appl Environ Microbiol (1987) 1.33
Enumeration and characterization of Aeromonas hydrophila and Aeromonas caviae isolated from grocery store produce. Appl Environ Microbiol (1987) 1.32
Molecular cloning and characterization of an extracellular protease gene from Aeromonas hydrophila. J Bacteriol (1990) 1.08
Aeromonas hydrophila isolated from food and drinking water: hemagglutination, hemolysis, and cytotoxicity for a human intestinal cell line (HT-29). Appl Environ Microbiol (1996) 0.99
Pathogenicity factors and virulence for rainbow trout (Salmo gairdneri) of motile Aeromonas spp. isolated from a river. J Clin Microbiol (1990) 0.99
Characterization of the Aeromonas hydrophila group isolated from retail foods of animal origin. J Clin Microbiol (1989) 0.95
Comparison of the microbiological quality of water coolers and that of municipal water systems. Appl Environ Microbiol (1994) 0.94
Insight into the mobilome of Aeromonas strains. Front Microbiol (2015) 0.89
Influence of modified-atmosphere storage on the growth of uninjured and heat-injured Aeromonas hydrophila. Appl Environ Microbiol (1989) 0.87
Incidence of Aeromonas spp. infection in fish and chicken meat and its related public health hazards: A review. Vet World (2016) 0.86
Growth of Aeromonas hydrophila on fresh vegetables stored under a controlled atmosphere. Appl Environ Microbiol (1989) 0.85
Differential media for quantitative recovery of waterborne Aeromonas hydrophila. Appl Environ Microbiol (1996) 0.83
Evaluation of several selective media for recovery of Aeromonas hydrophila from polluted waters. Appl Environ Microbiol (1988) 0.77
Draft Genome Sequence of Aeromonas sp. Strain EERV15. Genome Announc (2016) 0.75
Thermal Inactivation of Aeromonas hydrophila As Affected by Sodium Chloride and Ascorbic Acid. Appl Environ Microbiol (1993) 0.75
Growth of Aeromonas spp. on Butzler Campylobacter selective agar and evaluation of the agar for the primary isolation of Aeromonas spp. from clinical specimens. J Clin Microbiol (1989) 0.75
Microbiological quality of salmon (Salmo salar) sold in cities of the state of SãO Paulo, Brazil. Braz J Microbiol (2012) 0.75
Species Distribution and Prevalence of Putative Virulence Factors in Mesophilic Aeromonas spp. Isolated from Fresh Retail Sushi. Front Microbiol (2017) 0.75
A taxonomic study of the Aeromonas hydrophila-Aeromonas punctata group. J Gen Microbiol (1976) 5.33
Aeromonas-associated gastroenteritis. Lancet (1982) 4.17
Prevalence and distribution of Aeromonas hydrophila in the United States. Appl Environ Microbiol (1978) 4.15
Medium for the isolation of Aeromonas hydrophila. Appl Microbiol (1973) 2.70
The microbiology of childhood gastroenteritis: Aeromonas species and other infective agents. J Infect Dis (1983) 2.53
Medium for the presumptive identification of Aeromonas hydrophila and Enterobacteriaceae. Appl Environ Microbiol (1979) 2.49
Enterotoxin production in relation to taxonomic grouping and source of isolation of Aeromonas species. J Clin Microbiol (1984) 2.27
Evaluation of differential and selective media for isolation of Aeromonas and Plesiomonas spp. from human feces. J Clin Microbiol (1983) 2.16
Nature, characteristics, and proteolytic properties of beef spoilage bacteria at low and high temperatures. Appl Microbiol (1967) 2.12
Membrane filter procedure for enumeration of Aeromonas hydrophila in fresh waters. Appl Environ Microbiol (1979) 1.89
Effect of packaging under carbon dioxide, nitrogen or air on the microbial flora of pork stored at 4 degrees C. J Appl Bacteriol (1979) 1.23
Bacteria associated with crabs from cold waters with emphasis on the occurrence of potential human pathogens. Appl Environ Microbiol (1984) 0.97
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet (1992) 3.30
Problems in assessing contents of metered dose inhalers. BMJ (1993) 3.07
Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res (1979) 2.61
Aldehydes and ketones produced during fermentation of glucose by Escherichia coli. J Bacteriol (1967) 2.08
Minimum standards for the management of cleft lip and palate: efforts to close the audit loop. Royal College of Surgeons of England. Ann R Coll Surg Engl (1996) 1.72
CFS hydroxylase cofactor levels in some neurological diseases. J Neurol Neurosurg Psychiatry (1980) 1.59
Raised cerebrospinal-fluid copper concentration in Parkinson's disease. Lancet (1987) 1.48
Plasma cysteine and sulphate levels in patients with motor neurone, Parkinson's and Alzheimer's disease. Neurosci Lett (1990) 1.47
Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci (1999) 1.45
Influence of surgeon's experience on speech outcome in cleft lip and palate. Lancet (1999) 1.44
Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci (2008) 1.43
Migraine after bone-marrow transplantation. Lancet (1989) 1.43
Updated guidelines for the management of Parkinson's disease. Hosp Med (2001) 1.41
Virulence of an Escherichia coli O157:H7 sorbitol-positive mutant. Appl Environ Microbiol (1993) 1.40
The incidence of impacted teeth. A survey at Harlem hospital. Oral Surg Oral Med Oral Pathol (1970) 1.35
Facultative wood-digesting bacteria from the hind-gut of the termite Reticulitermes hesperus. J Gen Microbiol (1976) 1.34
Submandibular duct sialolith of unusual size and shape. J Oral Surg (1975) 1.31
Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev (2003) 1.30
Reduction of Salmonella spp. and strains of Escherichia coli O157:H7 by gamma radiation of inoculated sprouts. J Food Prot (2000) 1.26
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Sexual difficulties of chronic pain patients. Clin J Pain (2001) 1.25
Long-term treatment of parkinsonism with bromocriptine. Lancet (1978) 1.24
Regulation of aflatoxin biosynthesis: assessment of the role of cellular energy status as a regulator of the induction of aflatoxin production. Appl Environ Microbiol (1987) 1.24
Studies on Escherichia coli serotype O157:H7 strains containing a 60-MDa plasmid and on 60-MDa plasmid-cured derivatives. J Med Microbiol (1993) 1.21
The cellulase system of a Cytophaga species. Can J Microbiol (1977) 1.21
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 3: speech outcomes. Cleft Palate Craniofac J (2001) 1.21
Systematic review of outpatient services for chronic pain control. Health Technol Assess (1997) 1.19
Encephalopathy associated with ifosphamide/mesna therapy. Lancet (1985) 1.17
Xenobiotic metabolism in motor neuron disease. Lancet (1988) 1.16
Xenobiotic metabolism in Parkinson's disease. Neurology (1989) 1.16
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int J Pharm (2000) 1.15
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 4: outcome comparisons, training, and conclusions. Cleft Palate Craniofac J (2001) 1.12
Acute angle-closure glaucoma following botulinum toxin injection for blepharospasm. Br J Ophthalmol (1990) 1.10
Fate of Escherichia coli O157:H7 on fresh-cut apple tissue and its potential for transmission by fruit flies. Appl Environ Microbiol (1999) 1.10
Alfalfa seed germination and yield ratio and alfalfa sprout microbial keeping quality following irradiation of seeds and sprouts. J Food Prot (2001) 1.09
The development of a battery of measures for assessing physical functioning of chronic pain patients. Pain (1994) 1.08
Toxic fluorine compounds. 20. The use of the omega-fluorine atom in the study of the metabolism of branched-chain fatty acids. Biochem J (1964) 1.07
Spinal cord stimulation and the relief of chronic pain. J Neurol Neurosurg Psychiatry (1987) 1.06
Carboxymethylcellulase produced by facultative bacteria from the hind-gut of the termite Reticulitermes hesperus. J Gen Microbiol (1978) 1.06
Regulation of aflatoxin biosynthesis: effect of glucose on activities of various glycolytic enzymes. Appl Environ Microbiol (1984) 1.04
Cleft lip and palate care in the United Kingdom--the Clinical Standards Advisory Group (CSAG) Study. Part 1: background and methodology. Cleft Palate Craniofac J (2001) 1.03
Effect of initial pH on aflatoxin production. Appl Microbiol (1975) 1.02
Extrapyramidal reactions to anti-inflammatory drugs. J Neurol Neurosurg Psychiatry (1988) 1.02
Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease. Science (1979) 1.01
Smoking habits of Florida physicians revisited. JFMA (1972) 1.01
Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol (1999) 1.01
Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer (1970) 1.01
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma cells: a possible role for cyclooxygenase 2. Gut (2005) 1.00
Stridor during dystonic phases of Parkinson's disease. J Neurol Neurosurg Psychiatry (1987) 1.00
Patients' and professionals' understandings of the causes of chronic pain: blame, responsibility and identity protection. Soc Sci Med (1997) 0.99
Motoneurone disease as manifestation of pesticide toxicity. Lancet (1987) 0.99
Idiopathic dysautonomia treated with intravenous gammaglobulin. Lancet (1996) 0.98
Derepression of synthesis of the aminoacyl-transfer ribonucleic acid synthetases for the branched-chain amino acids of Escherichia coli. J Bacteriol (1974) 0.98
Comparison of batch and semicontinuous cultures for production of protein from mesquite wood by Brevibacterium sp. JM98A. Biotechnol Bioeng (1975) 0.98
Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. J Pharm Pharmacol (2001) 0.98
Mechanisms of inhibition of mononuclear cell activation by the iron-chelating agent desferrioxamine. Immunology (1990) 0.98
Factor interactions at simian virus 40 GC-box promoter elements in intact nuclei. Mol Cell Biol (1987) 0.98
Bax inhibitor 1 in apoptosis and disease. Oncogene (2011) 0.97
Loss of APC protein expressed by human colonic epithelial cells and the appearance of a specific low-molecular-weight form is associated with apoptosis in vitro. Int J Cancer (1994) 0.97
Are the Peer Assessment Rating Index and the Index of Treatment Complexity, Outcome, and Need suitable measures for orthognathic outcomes? Eur J Orthod (2006) 0.96
Caffeine inhibition of aflatoxin production: mode of action. Appl Environ Microbiol (1983) 0.96
Reduction of endogenous nucleic acid in a single-cell protein. Appl Environ Microbiol (1979) 0.96
Colorectal carcinogenesis: sequential steps in the in vitro immortalization and transformation of human colonic epithelial cells (review). Anticancer Res (1990) 0.95
Enterotoxin A production in Staphylococcus aureus: inhibition by glucose. Arch Microbiol (1986) 0.95
Characterization of the Aeromonas hydrophila group isolated from retail foods of animal origin. J Clin Microbiol (1989) 0.95
The proapoptotic BH3-only protein Bim is downregulated in a subset of colorectal cancers and is repressed by antiapoptotic COX-2/PGE(2) signalling in colorectal adenoma cells. Oncogene (2010) 0.95
Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis (2005) 0.94
S-methylation in motorneuron disease and Parkinson's disease. Lancet (1989) 0.94
Development of a quantitative risk assessment model for Salmonella enteritidis in pasteurized liquid eggs. Int J Food Microbiol (1997) 0.94
Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells. Carcinogenesis (2003) 0.94
Plagiarism, retraction and the future. Hum Reprod (2011) 0.94
Terpene penetration enhancers in propylene glycol/water co-solvent systems: effectiveness and mechanism of action. J Pharm Pharmacol (1995) 0.93
Deterioration of Wilson's disease following the start of penicillamine therapy. Arch Neurol (1989) 0.92
Opiate reduction in chronic pain patients: a comparison of patient-controlled reduction and staff controlled cocktail methods. Pain (1994) 0.92
Characterization of dihydrates prepared from carbamazepine polymorphs. J Pharm Sci (1996) 0.92
Hyponatraemia as a cause of reversible ataxia. Br Med J (Clin Res Ed) (1986) 0.92
Activation of cathepsin B, secreted by a colorectal cancer cell line requires low pH and is mediated by cathepsin D. Int J Cancer (1996) 0.91
Surgery for Parkinson's disease: lack of reliable clinical trial evidence. J Neurol Neurosurg Psychiatry (2003) 0.91
Toxicity of sulphur-containing compounds to neuronal cell lines. J Neurol Sci (1995) 0.91
Caffeine inhibition of aflatoxin synthesis: probable site of action. Appl Environ Microbiol (1984) 0.91
Evidence of enhanced lipid peroxidation in the cerebrospinal fluid of patients taking phenothiazines. Lancet (1987) 0.90
Effect of low dose gamma radiation on lipids in five different meats. Meat Sci (1996) 0.90
Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group. Hosp Med (1998) 0.90
Prospects in NSAID-derived chemoprevention of colorectal cancer. Biochem Soc Trans (2005) 0.90
Skin hydration and possible shunt route penetration in controlled estradiol delivery from ultradeformable and standard liposomes. J Pharm Pharmacol (2001) 0.90
Cannabinoids and cancer: potential for colorectal cancer therapy. Biochem Soc Trans (2005) 0.89
Bonding of metal attachments to teeth for treatment of mandibular fractures. J Oral Surg (1974) 0.89
Effect of NaCl, pH, temperature, and atmosphere on growth of Salmonella typhimurium in glucose-mineral salts medium. Appl Environ Microbiol (1987) 0.88
Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm (2004) 0.88
Irradiation killing of Toxoplasma gondii oocysts. J Eukaryot Microbiol (1996) 0.88
Effect of gamma irradiation on unsporulated and sporulated Toxoplasma gondii oocysts. Int J Parasitol (1998) 0.88
An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol (1995) 0.88
IGFBP-3 and apoptosis--a license to kill? Apoptosis (2001) 0.88
The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells. Cell Death Dis (2012) 0.87
The neuropathy of the critically ill. Br Med J (Clin Res Ed) (1986) 0.87
Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int J Pharm (2000) 0.87
In vitro effect of the cysteine metabolites homocysteic acid, homocysteine and cysteic acid upon human neuronal cell lines. Neurotoxicology (1998) 0.87